Skip to content

Promoting smoking cessation following a smoke-free mental health stay

Promoting Smoking CEssation and PrevenTing RElapse to tobacco use following a smoke-free mental health inpatient stay (SCEPTRE programme): a pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN38227785
Enrollment
12
Registered
2022-03-02
Start date
2022-03-14
Completion date
Unknown
Last updated
2023-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking cessation following a smokefree mental health stay Mental and Behavioural Disorders

Interventions

The intervention consists of components that aim to support smoking-related behavioural change among patients following discharge from a smoke-free mental health setting. The intervention will be deli

Sponsors

Sheffield Health and Social Care NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients: 1. Adults aged 18 years and older (no maximum age) 2. Present admission to an acute inpatient mental health setting 3. Planned discharge to own residence or step-down setting 4. Tobacco smokers at the time of admission who express an interest in maintaining abstinence (if smokefree at time of assessment) or positively changing their smoking behaviour following discharge (including harm reduction and e-cigarette approaches) 5. Patients living in the catchment area of the Trust where they are admitted 6. Able to understand and communicate in English 7. Able to provide informed consent Carers: 1. Adults aged 18 years and older (no maximum age) 2. Carers, family members or friends of patients who are currently admitted to an acute inpatient mental health setting 3. Carers, family members or friends of patients who are self-identified tobacco smokers at time of admission who express an interest in maintaining abstinence (if smokefree at time of assessment) or positively changing their smoking behaviour following discharge (including harm reduction and e-cigarette approaches) 4. Carers, family members or friends of patients who have consented to receiving the SCEPTRE intervention 5. Carers, family members or friends who are in regular contact with the patient and therefore able to provide feedback about the SCEPTRE intervention, what worked well for the patient, and what needs to be improved 6. Able to understand and communicate in English 7. Able to provide informed consent

Exclusion criteria

Exclusion criteria: Patients: 1. Admitted under the care of older adult, learning disability, psychiatric intensive-care unit (PICU) or forensic mental health services 2. Patients with co-morbid drug or alcohol problems (dual diagnosis) 3. Patients who are pregnant or breastfeeding 4. Patients may also be excluded for any other reason at the discretion of their regular treating clinician. Carers: Carers may be excluded for any other reason at the discretion of their regular treating clinician

Design outcomes

Primary

MeasureTime frame
The usability of the manual and research measures, participant and staff acceptability (including interest in participation, consent, and engagement), and feedback relating to the research participation process and the intervention (as a whole and in terms of single components), assessed using interviews conducted with participants and staff members within 1-week post-intervention

Secondary

MeasureTime frame
1. Mental health assessed using Recovering Quality of Life (ReQoL-10), Patient Health Questionnaire (PHQ-8), Generalized Anxiety Disorder (GAD-2) at baseline and 1-week post-intervention 2. Physical health assessed using self-reported physical health state, body mass index (BMI) at baseline and 1-week post-intervention 3. Smoking history and behaviour, including nicotine dependence (Fagerstrom Test of Nicotine Dependence), level of motivation to quit (Motivation to Quit Questionnaire) and intentions to quit post-discharge, assessed using a questionnaire at baseline and 1-week post-intervention

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026